Vimarsana
Biggest News Aggregation in the World

Finance Contract News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Finance Contract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Finance Contract Today - Breaking & Trending Today

BBCNEWS World Business Report April 13, 2017 - Vimarsana News

BBCNEWS World Business Report April 13, 2017

Can americas Banking Giants back their sky high share prices with sky high profits . Plus, scooter boys beware why your Takeaway Food could soon be arriving by robot. Im aaron heslehurst. Welcome to World Business report. Lots going on. If you give me about eight minutes i will give you a snapshot of all the latest in the world of his ascent of money. World of his ascent of money. World of his ascent of money. World of business. Also coming up, more surprises from President Trump as he eases Trade Tensions with china. We start on wall street, where its a hugely important day for investors. Now...

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023 - Vimarsana News

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023

•   Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting •   Execution of strategic...

Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux -January 24, 2024 at 04:16 pm EST - Vimarsana News

Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux -January 24, 2024 at 04:16 pm EST

       Daix , Long Island City , January 24, 2024 – Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of...

Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank - Vimarsana News

Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank

Inventiva intends to use the proceeds to fund part of its ongoing pivotal NATiV3 Phase III clinical trial evaluating lanifibranor in patients with...

Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023 - Vimarsana News

Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023

•  Strategic Collaboration and Investment Agreements signed with AstraZenecaUpdated results of the Phase I BALLI-01 Trial evaluating UCART22 in r/...